GIANT Technology
High-precision microfluidics for rapid, versatile antimicrobial and small-molecule screening.
How It Works
GIANT uses high-precision microfluidics to run AST in sub-microliter or nanoliter-size chambers, reducing sample volume while accelerating time to result.
One-Step Loading
Simple workflow designed for speed and usability in real clinical settings.
2-Hour Incubation
Rapid readout enables earlier targeted therapy decisions.
Easy Analysis
Compatible with a commercial plate reader or a mobile device.
Platform Highlights
Fastest AST Platform
2 hours time to result.
Small Sample Volume
200× reduction in sample volume (typical ~50–100 µL range noted).
High Accuracy
>95% agreement with gold standard (BMD) across >400 clinical samples.
Low Cost Per Test
Cost-effective with strong margin potential.
Clinical & Technical Validation
Beating the Gold Standard
Delivers results in 2 hours versus traditional gold standard workflows that take >24 hours.
Clinical Evidence
>400 tested clinical samples with >95% agreement with gold standard (BMD).
IP & Publications
Backed by 4 patents and 6 publications.